Full Text View
Tabular View
No Study Results Posted
Related Studies
Rosiglitazone-Induced Weight Gain
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Stanford University.
Recruitment status was  Recruiting
Study NCT00225225   Information provided by Stanford University

First Received on September 21, 2005.   Last Updated on February 21, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
Weight Gain
More general conditions related to this trial
Body Weight
Body Weight Changes
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Signs and Symptoms
Interventions listed in this trial
Rosiglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Stanford University
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services